RESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for post-cardiac arrest refractory status epilepticus treatment.
RESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for post-cardiac arrest refractory status epilepticus treatment.
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
-
Zuckerberg San Francisco General Hospital, San Francisco, California, United States, 94110
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
University of California, San Francisco,
Edilberto Amorim, MD, PRINCIPAL_INVESTIGATOR, Assistant Professor of Neurology
2025-04-30